All In MedTech

Device Trial Radar · NCT05197803

Clinical Study of Released Unitron RIC and BTE Hearing Aid Models

Clinical Study of Released Unitron RIC (Receiver in Canal) and BTE (Behind the Ear) Hearing Aid Models

Last checked: Nov 19, 2026Latest source record: May 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

25

Actual

Start

Jan 10, 2022

Primary completion

Jan 28, 2022

Study completion Jan 28, 2022

Sponsor

Lead sponsor
Sonova AGNot on our public-company list
Sponsor type
Industry
Collaborators
Sonova Canada Inc.
First posted
Jan 20, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The present study will confirm the clinical benefit of 2 different released hearing aid models for speech understanding (in noise). Participants with mild to severe hearing impairment will be fit binaurally with Unitron hearing aids and will perform a standardized speech discrimination test in noise with and without hearing aids.

Conditions

  • Hearing Loss

Interventions

  • Hearing aidDevice

    Participants will complete testing aided and unaided. The hearing aids have been fit to compensate for their hearing loss.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Speech Intelligibility Test in NoiseTime frame: 2 hours appointment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Unitron Hearing

    Kitchener, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.